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Abstract
Background: Hyponatremia is the most frequent electrolyte abnormality observed in post-operative pediatric
patients receiving intravenous maintenance fluid therapy. If plasma sodium concentration (p-Na
+) declines to levels
below 125 mmol/L in < 48 h, transient or permanent brain damage may occur. There is an intense debate as to
whether the administered volume (full rate vs. restricted rate of infusion) and the composition of solutions used for
parenteral maintenance fluid therapy (hypotonic vs. isotonic solutions) contribute to the development of
hyponatremia. So far, there is no definitive pediatric data to support a particular choice of parenteral fluid for
maintenance therapy in post-surgical patients.
Methods/Design: Our prospective randomized non-blinded study will be conducted in healthy children and
adolescents aged 1 to 14 years who have been operated for acute appendicitis. Patients will be randomized either
to intravenous hypotonic (0.23% or 0.40% sodium chloride in glucose, respectively) or near-isotonic (0.81% sodium
chloride in glucose) solution given at approximately three-fourths of the average maintenance rate. The main
outcome of interest from this study is to evaluate 24 h post-operatively whether differences in p-Na
+ between
treatment groups are large enough to be of clinical relevance. In addition, water and electrolyte balance as well as
regulatory hormones will be measured.
Discussion: This study will provide valuable information on the efficacy of hypotonic and near-isotonic fluid
therapy in preventing a significant decrease in p-Na
+. Finally, by means of careful electrolyte and water balance
and by measuring regulatory hormones our results will also contribute to a better understanding of the
physiopathology of post-operative changes in p-Na
+ in a population at risk for hyponatremia.
Trial registration: The protocol for this study is registered with the current controlled trials registry; registry
number: ISRCTN43896775.
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Hyponatremia, as defined by plasma sodium concentra-
tion (p-Na
+) < 136 mmol/L, is the most common elec-
trolyte abnormality in post-operative pediatric patients
receiving parenteral maintenance fluid therapy [1].
Patients with hospital-acquired hyponatremia are
exposed to major neurological complications if p-Na
+
declines to ~ 120 mmol/L in < 48 h [2].
Post-operative hyponatremia has been attributed to
either an excess of delivered water or a net sodium defi-
cit [1,3-5]. A series of pediatric investigations support
the notion that a hospital acquired decrease in p-Na
+ in
ill children receiving parenteral fluid therapy is the
result of administering an excess of water relative to
sodium, i.e., hypotonic saline solutions [6,7]. However,
there is no definitive pediatric data to support a particu-
lar choice of parenteral fluid for maintenance therapy to
prevent hyponatremia in either post-surgical patients or
critically ill medical patients [8-10]. Therefore, data
obtained by means of well-designed randomized clinical
trials remains a pressing priority if uncertainties in the
prescription of parenteral maintenance fluid therapy are
to be resolved [11,12]. Based on previous lines of evi-
dence, such an investigation should take into account
the following facts: i) healthy kidneys are able to greatly
vary the amount of water and sodium excreted to match
the water and salt intake and therefore preserve the sta-
bility of the extracellular fluid compartment and main-
tain p-Na
+ within the physiological range [13,14], ii)
conditions such as stress (e.g., pain, fever, and surgery),
hypovolemia, vomiting, nausea, anesthesia, and intra-
operative bowel manipulation are known non-osmotic
stimuli for the production of antidiuretic hormone
(ADH) [3,15-17], and iii) increased ADH levels impair
the urinary dilution capacity and as a result free water
retention in excess of sodium may ensue [18,19].
Taking this information into account, prescription of
parenteral fluid therapy following a surgical intervention
might pose a risk for a decrease in p-Na
+ whenever the
kidneys lack the capacity to excrete an excess of water
load [20,21]. Under such circumstances, hyponatremia
would be the result of dilution of body solutes, i.e., an
excess of water in relation to the existing sodium stores
rather than to an increase in urinary sodium excretion.
This suggests that after surgery, the prescription of par-
enteral maintenance fluid therapy should be tailored to
the patient’s water and electrolyte needs [22]. Indeed, in
recent years it has been recommended to prescribe half
the average of daily physiological losses as a measure to
prevent post-operative hyponatremia [12,23,24]. This
recommendation appears to be appropriate whenever the
patient’s extracellular fluid compartment is preserved
and the urinary dilution capacity is suspected to be
impaired by non-osmotic stimulated ADH activity [8].
Conversely, there is data supporting the view that
hyponatremia might ensue due to desalination followed
by the administration of intravenous replacement with
hypotonic fluids [23]. It has been proposed that post-
operative hyponatremia would be avoided by using iso-
tonic saline instead of hypotonic saline for parenteral
maintenance fluid therapy [11,25]. There is however no
consensus as to whether or not the isotonic saline infu-
sion rate should be restricted [11,25]. Notwithstanding
this, a fall in p-Na
+ has also been also observed in surgi-
cal patients receiving near-isotonic saline infusions [26].
Based on existing pediatric data, it appears that tailor-
ing post-operative parenteral fluid therapy to the indivi-
dual patient’s needs would be the most appropriate
physiological approach, since no simple parenteral fluid
therapy seems likely to be safely used in this clinical set-
ting. Nevertheless, there is so far no study that suggests
how this should be done.
At our hospital, the routine procedure for immediate
post-operative parenteral maintenance fluid therapy
consists of the use of near half-isotonic solution (0.40%
salt solution, 70 mmol/L Na
+ + 45 mmol/L Cl
- +2 5
mmol/L acetate in 2.5% glucose) given at low mainte-
nance rate, i.e., at ~¾ the average maintenance rate. The
administration of sodium acetate is intended as an alter-
native to NaCl as a source of sodium ion in a large
volume infusion. In addition, acetate is an alternative
source of bicarbonate by metabolic conversion in the
liver. Although in our own experience (UF and PAL,
unpublished data), no patient treated in this way has
experienced hyponatremia of potential clinical signifi-
cance, defined as a fall in p-Na
+ fall < 130 mmol/L [27],
our routine procedure does not rely on evidence-based
medicine, but on theoretical grounds. Therefore, a well
designed study seems warranted to determine the par-
enteral fluid regimen that can effectively and accurately
be prescribed to post-operative pediatric patients [28].
In addition, logic-based evidence for appropriate labora-
tory monitoring is also justified.
In this paper, we detail our study protocol for a pro-
spective randomized non-blinded investigation aimed at
evaluating the efficacy of hypotonic and near-isotonic
saline for parenteral fluid therapy given at low mainte-
nance rate in post-operative pediatric patients, using p-
Na
+ as a surrogate marker. Since at our Center acute
appendicitis accounts for a large number of emergency
surgical admissions, our investigation will be conducted
in previously healthy children and adolescents who have
undergone acute appendectomy for complicated appen-
dicitis. The study will be started once the rationale
behind this investigation as well as the full description
of the protocol has reached the public domain. In so
doing, we expect to receive comments that would even-
tually contribute to improve our protocol [29].
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Objectives
Our primary outcome of interest is to evaluate whether
the post-operative prescription of either hypotonic or
near-isotonic fluid therapy given at low maintenance
rate in otherwise healthy children with normal post-
operative p-Na
+ are equally effective in maintaining p-
Na
+ within the normal range. In addition, our secondary
aim is to determine water and electrolyte-balance fol-
lowing the administration of the investigational parent-
eral maintenance fluids as well as to investigate known
regulatory hormones involved in the homeostatic con-
trol of water balance. Finally, we will seek to determine
how frequently p-Na
+ should be monitored during the
post-operative period.
Study Design
The present investigations will be set up as a prospec-
tive randomized non-blinded study. Eligible patients will
be randomly assigned to rec e i v eo n eo ft h ef o l l o w i n g
electrolyte/glucose combinations as parenteral mainte-
nance fluid therapies during the 24 h following surgery:
i) 0.23% sodium chloride (40 mmol/L Na
+ + 20 mmol/L
K
+ + 60 mmol/L Cl
-; extempore solution) in 5% glucose,
ii) 0.40% sodium chloride (70 mmol/L Na
+ + 45 mmol/
LC l
- + 25 mmol/L acetate; B. Braun Melsungen AG,
Melsungen, Germany) in 2.5% glucose, or iii) 0.81%
sodium chloride (140 mmol/L Na
+ +4m m o l / LK
+ +1
mmol/L Ca
2+ + 1 mmol/L Mg
2+ + 118 mmol/L Cl
- +3 0
mmol/L acetate; Serumwerk Bernburg AG, Bernburg,




2+,a n dM g
2+ refer to potassium, chloride, calcium,
and magnesium, respectively).
Ethical Considerations
The study protocol has been approved by the Medical
Ethics Committee at Karolinska University Hospital,
Stockholm, Sweden (Protocol No. 2010/2:9). The study
protocol was registered at current clinical trials registry
database; http://www.controlled-trials.com/ISRCTN
43896775, registry number: ISRCTN43896775).
A written and verbal version of the information will
be presented to the potentially eligible patient and par-
ents before the surgical procedure by the surgeon in
charge of the patient. The exact nature of the study, the
implications and constraints of the protocol, the known
side effects, and any risks involved in taking part will be
detailed. Parents and patients will be told that all study
findings will be handled in strictest confidentiality and
that it extends beyond the duration of the study. It will
be clearly stated that the patient and parents are free to
withdraw from the study at any time for any reason
without prejudice to future care, and with no obligation
to give the reason for withdrawal. Written informed
consent will then be obtained by means of a dated
patient’s and parent’s signature and dated signature of
the surgeon who presented the informed consent form.
A copy of the signed informed consent will be given to
the patient.
Study Population and Site
The participants will be recruited at the Department of
Pediatric Surgery, Astrid Lindgren Children’sH o s p i t a l ,
at the Karolinska University Hospital, Solna, Sweden.
Potentially eligible participants in the study will be
healthy children and adolescents consecutively operated
for emergency abdominal surgery due to acute
appendicitis.
Our Center is an academic teaching hospital that pro-
vides care in the majority of pediatric surgical cases in
the greater Stockholm area, covering a population of
about 1,8 million inhabitants, which corresponds to a
referral area of approximately 350,000 children. More
than 300 children and adolescents are admitted for
treatment of acute appendicitis every year. The date for
enrolment to the clinical trial will be defined once the
protocol has reached public domain. The study will take
place in the Pediatric Intensive Care Unit, Astrid Lindg-
ren Children’s Hospital, at the Karolinska University
Hospital, Solna, Sweden.
Eligibility Criteria
In the present investigation, we arbitrarily decided not
to include children aged less than 1 year of age because
the functional capacity of the kidney, including glomeru-
lar filtration rate and renal concentration ability, as well
as the efficiency to excrete sodium load is lower in
infants than in older children [30-33]. Hence, the study
population will be male and female children and adoles-
cents aged between 1 and 14 years old whose post-
operative p-Na
+ are within the normal range (local
reference range: 135 - 147 mmol/L). Children and ado-
lescents undergoing emergency intervention for treat-
ment of acute appendicitis either as an open or
laparoscopic procedure will be considered to be poten-
tially eligible. To qualify for randomization, the partici-
pants are required to have a complicated appendicitis, i.
e., gangrenous or perforated, either with generalized or
localized peritonitis of such a degree that the surgeon
considers oral feeding unsuitable for at least 24 h fol-
lowing the surgery. Consequently, the randomization
will be performed post-operatively and on the basis of
intra-operative findings.
We infer that in our study population, the prescription
of parenteral fluid therapy for the immediate 24 h post-
operative period might be justified, and that by delaying
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no harm to the patient.
The exclusion criteria will be any clinical condition,
such as renal disease, acute or chronic lung inflamma-
tion, pituitary or hypothalamic disease, and adrenal
insufficiency that eventually can lead to electrolyte and
water imbalance. In addition, any patient whose p-Na
+
is < 130 mmol/L after the initiation of parenteral main-
tenance fluid therapy, will be withdrawn from the study
and treated accordingly at the discretion of the anesthe-
siologist responsible for the patient’s care [34].
Whenever the occurrence of vomiting is reported or if
the patient complains of symptoms attributable to
symptomatic hyonatremia such as nausea, malaise, head-
ache, restlessness, drowsiness, or decreased conscious-
ness, p-Na
+ will be immediately controlled and the
event clearly documented in the medical record.
During the first 24 h post-operatively, the administra-
tion of extra fluid besides the study maintenance fluid
therapy, will be not permitted with the exception of
fluid administered with medication or to maintain
patency of peripheral intravenous catheters.
Analysis population
Three analysis populations will be used in this study.
The “intention to treat” population will consist of all
subjects who have been randomized and have received
one of three parenteral maintenance fluid therapies pre-
viously mentioned. The analysis will be conducted in all
“intention to treat” patients who had no protocol viola-
tion(s) or deviation(s).
Patient Randomization
The study population will be allocated to each of the
intervention groups using randomization in blocks.
Block size will be kept secret to all study related person-
nel. Participants will be numbered sequentially. It is
expected that after the randomization there will be no
differences in the clinical or biochemical characteristics
among different treatment groups at the start of post-
operative parenteral fluid therapy. After randomization,
the anesthetist and the clinical team will be informed by
the surgeon to which fluid regimen arm the patient has
been allocated.
Clinical and Laboratory Assessment
Upon admission from surgery and by the end of the
first post-operative day, patients will be weighted (kg).
In addition, height (m) will be measured and body
mass index (kg/m
2) calculated. Non-invasive blood
pressure (mm Hg), heart rate (beats per minute), mon-
itoring of arterial oxygen saturation with pulse oxime-
try, and body temperature will be recorded at regular
intervals.
Blood samples will be collected immediately after the
conclusion of surgery (T0), at 6 h (T6)a n d1 2h( T 12),
and then at 24 h (T24) following the surgery. The blood




-, creatinine, urea, uric acid, glu-
cose, lactate, ketones, renin, aldosterone, ADH, hemo-
globin, blood gas, and for serum (s) osmolality by means
of routine and quality controlled laboratory techniques.
Serum Cortisol and s-TSH (thyroid-stimulating hor-
mone) will be measured at T0.A tT 12, p-Na
+, p-glucose,
and blood gas will be monitored. The blood samples
obtained at T6 and T12 will be analyzed for p-Na
+. Also,
at the discretion of the treating anesthesiologist, p-Na
+
will be monitored at intermediate sampling if p-Na
+ at
T12 follows a decreasing trend.
Entire urine collection from T0 to T24 will be obtained
by urine bag or clean catch, as appropriate. A bladder
scan will be performed whenever urinary retention is
suspected. Depending on the bladder volume measured,
urethra catheterization will be performed to relieve
urine retention if the patient cannot void on his/her
own. Adequacy of timed urine collection will be con-
firmed as far as possible by estimation of urinary creati-
nine excretion rate (mmol/kg per 24 h) [35].
In addition to measuring total urine volume, urinary
sodium, potassium, and chloride excretion, we will cal-
c u l a t e ,f r o ms p o tu r i n es a m p l e so b t a i n e da tT 0 and T24,
the fractional excretion of sodium (FeNa), the fractional
excretion of uric acid (FeUA), and the urine osmolality.
T h eF e N a[ ( u - N a
+ × p-creatinine) ÷ (p-Na
+ ×u - c r e a -
tinine) × 100] is the fraction of sodium filtered by the
glomeruli that appears in the urine. The extracellular
fluid compartment is regulated by changes in sodium
excretion and when the extracellular fluid is contracted
(e.g., intra-operative hypovolemia due to blood loss),
urinary sodium can be undetectable. The FeNa is there-
fore a useful laboratory investigation to differentiate
hypovolemic, i.e., a decrease of the effective arterial
blood volume, from euvolemic state [36]. On the other
hand, hypervolemic state enhances FeNa, an effect inde-
pendent of the increase in urinary flow.
In the event of non-osmotic excess secretion of ADH,
as it has been observed in post-operative patients, gener-
ous intake of solute-poor fluid might result in a positive
water balance. If post-operative fluid prescription is
however limited, as we intend in our study, the extracel-
lular fluid compartment (and total body fluid) will not
be expected to expand. Consequently, the FeNa at T24
should not be significantly different compared to T0.
Uric acid urinary excretion is regulated to changes in
the effective arterial blood volume [37]. Therefore,
FeUA [(u-UA × p-creatinine) ÷ (p-UA × u-creatinine) ×
100] is also useful to indirectly infer the effective arterial
blood volume, provided that the renal proximal tubule
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laboratory investigations will provide an insight into
how a child’s kidneys are handling water and salt.
Urine analysis, including osmolality, will be performed
by using routine and quality controlled techniques.
Taken together, FeNa, FeUA, total urinary electrolyte
excretion, urine osmolality, ADH, as well as p-renin and
p-aldosterone activity will be interpreted in the context
of the patient’s water and electrolyte balance.
Finally, serum (~3 ml), and urine samples (~15 ml),
obtained at T0 and T24 will be stored -80°C in a biobank
(duration of storage 10 years) for eventual future
analysis.
Parenteral Fluid Therapy
Intra-operative fluid management: following our routine
procedure, the volume of intra-operative fluid will be
adapted to the severity of surgical trauma as follows; i)
mild trauma, 5 ml/kg body weight (BW) per h, ii) mod-
erate trauma, 7.5 ml/kg BW per h, and iii) severe
trauma, 10 ml/kg BW per h. The parenteral fluid used
intra-operatively, i.e., from the start of the surgery to T0,
will consist of 0.40% salt solution (70 mmol/L Na
+ +4 5
mmol/L Cl
- + 25 mmol/L acetate) in 2.5% glucose (B.
Braun Melsungen AG, Melsungen, Germany).
During surgery, appropriate amount of intravenous
isotonic fluid blouses will be administered whenever
hypovolemia is suspected to ensure adequate intravascu-
lar volume and oxygen delivery. The duration of
anesthesia and all intra-operative inputs will be docu-
mented in the medical record. In addition, we will have
free and open access to data concerning patient’sp r e -
operative intravenous fluid therapy.
Post-operative fluid management: the fluid needs for
parenteral therapy will be estimated based on metabolic
requirements of the body, i.e., expenditure of energy, as
described by Holliday and Segar where daily caloric
expenditure is equal to 100 cal/kg BW up to 10 kg,
1000 cal + 50 cal/kg BW from 11 to 20 kg, and 1500 cal
+ 20 cal/kg BW over 20 kg [22]. Under normal condi-
tions, the average needs of water for replacement of
usual insensible and urinary water losses is directly
related to the metabolic rate, and when expressed in
milliliters, equals the estimated daily energy expenditure
in calories [22]. Depending on age, the amount of water
that accounts for insensible water losses varies from 45
to 59 ml/100 cal per 24 h, while the replacement of
urinary water losses will depend on the renal solute
load, i.e., the total daily excretion of solutes, and the
concentration of these solutes in the urine [22]. Holliday
and Segar estimated that a solute load of 40 mosmol/
100 cal per 24 h, a figure expected in the instance of
rational parenteral fluid therapy, would require ~60 ml
of water to be excreted, i.e., 60 ml/100 cal per 24 h.
This figure was calculated at a urine osmolality of 600
mosmol/kg H20, which was considered the maximum to
safely be expected from patients receiving parenteral
fluid therapy under normal conditions [22].
Since prescription of intravenous fluid therapy given at
full maintenance rate may be potentially dangerous
when renal water excretion is limited by ADH excess,
parenteral fluid therapy will be given at a lower rate
than the recommended average maintenance rate [8].
Consequently, and, in accordance with our local care
guidelines for parenteral fluid therapy following surgical
procedures, ~¾ of the average maintenance rate will be
prescribed for the first 24 h post-operatively, i.e., from
T0 to T24. Table 1 relates body weight to ~¾ of the
average maintenance allowances for hourly periods.
Ongoing post-operative losses, e.g., nasogastric drai-
nage following abdominal surgery, will be replaced ml
for ml with Ringer’s lactate solution.
Below, we describe an example of the likely change
in p-Na
+ that would result at T24 in a previously
healthy 10 year-old-boy who met the inclusion criteria
to participate in the study. We presuppose that our
hypothetical case has been randomized to be treated
with 0.23% salt solution in 5% glucose. We assume
Table 1 24 h post-operative fluid volume at ~¾ of
average maintenance rate according to Holliday-Segar
formula
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our study, his kidneys are capable of generating con-
centrated urine in response to non-osmotic stimulated
ADH activity. Since in the immediate post-operative
period a child with intact urinary concentration ability
m a ya c h i e v eu r i n eo s m o l a l i t yo fm o r et h a n7 0 0m o s -
mol/kg H2O as a result of elevated ADH levels [38], in
our example we arbitrarily set the urine osmolality at
900 mosmol/kg H2O.
In this hypothetical case we take into account all the
patient’s inputs during the 24 h period following sur-
gery, i.e., total volume of water, Na
+,K
+,a n dC l
-. Each
element is analyzed separately and it is supposed that all
the infused Na
+,K
+,a n dC l
- represent the renal solute
load that eventually will be excreted in the urine [39].
Thus, one mmol of each of these elements equals one
mosmol. Since glucose is metabolized to carbon dioxide
and water, it does not contribute to renal solute load in
our example. Similarly, in solutions containing acetate,
this anion is metabolized in the liver and does not con-
tribute to renal solute load.
It should be noted that, for the sake of simplicity, we
have chosen to take for granted that in this hypothetical
case the urine osmolality would be fixed during the 24 h
period following surgery. This, and the fact we only con-
sider the patient’s input of water and electrolyte, might
confine the accuracy in our predicting p-Na
+ at T24.
Therefore, in our study, the patient’s expected p-Na
+ at
T24 will be calculated by computing actual water and
electrolyte balance during the first 24 h post-operatively
as follows:
Na+
f =[ N a +
i × TBW + (Na+ +K +)] ÷ (TBW + TBW)
where the subscripts f and i represents final (T24)a n d
initial (T0)p - N a
+, respectively; Δ (Na
+ +K
+) represents
cation input (infused) minus cation output (urinary
excretion); TBW represents the estimated initial total
body water and ΔTBW describes the water infused
minus water excreted, respectively.
In our study we will analyze, by applying the same
approach as described in our hypothetical case, whether
p-Na
+ at T24 can be correctly estimated by using the
patient’s immediate postoperative urine osmolality value.
The estimated p-Na
+ obtained by this method and by
means of water and electrolyte balance will be plotted
against the patient’s actual p-Na
+ measured at T24 for
assessing agreement between methods [40].
Twenty-four hour insensible water losses in each par-
ticipant will be calculated as follows:
Insensible water losses (ml) = total infused fluid (ml) -
[urine output (ml) - change in body weight (g)]
Example
Weight = 30 kg. P-Na
+ at T0 = 140 mmol/L.
24 h infused volume according to study protocol
(Table 1) = 1410 ml.
24 h insensible (~45 ml/100 cal per 24 h) = 765 ml
[22].
The expected 24 h urine output needed to maintain
water balance will be as follows: infused volume - insen-
sible losses = 645 ml.
By infusing 0.23% salt solution (40 mmol/L Na
+ +2 0
mmol/L K
+ + 60 mmol/L Cl
-) in 5% glucose, the elec-
trolyte intake (and therefore excretion) will be expected
to be as follows:
56.4m m olN a+ +2 8.2m m olK + + 84.6 mmol Cl
− =1 69.2m m ol
At a fixed urine osmolality of 900 mosmol/kg H2O,
because of hypothetically persistent ADH release, our
example case will be expected to produce 188 ml urine
per 24 h (i.e., solute load of 169.2 mosmol ÷ urine
osmolality of 900 mosmol/kg H2O) [22]. As a conse-
quence, 457 ml of water will be retained (645 ml - 188
ml); ⅔ of this will distribute to the intracellular fluid
compartment and ⅓ to the extracellular fluid compart-
ment [41]. Since the apparent volume of distribution of
sodium is the total body water (TBW) [42], and the esti-
mated TBW accounts for 60% of body weight [43], the
expected change in p-Na
+ can be treated algebraically as
follows:
TBWi × Na+
i =T B W f × Na+
f
where the subscripts i and f represent initial and final
states, respectively. This equation states that the initial
volume × initial concentration = final volume × final
concentration. Since we assume that in our hypothetical
case there will be no change in total body sodium con-
tent by the end of the first postoperative 24 h, the p-Na
+
f is now the original sodium content divided by TWBf.
Thus, in our example the p-Na
+
f will be expected to be
136.5 mmol/L (i.e., p-Na
+
f =1 8L×1 4 0m m o l / L÷
18.457 L).
If we replace 0.23% sodium chloride parenteral fluid
therapy with either 0.40% sodium chloride or 0.81%
sodium chloride, the expected p-Na
+
f would be 136.4
mmol/L and 138.2 mmol/L, respectively.
Sample size calculation
The expected sample size required in our study is based
on the calculation for equality applied to the primary
outcome variable p-Na
+, measured at T24 as mmol/L.
In the previous section we estimated that the largest
expected fall in p-Na
+ in our illustrative case would be
3.6 mmol/L. Consequently, if we apply this figure to a
patient whose p-Na
+ at T0 is 135 mmol/L, the expected
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+ at T24 after giving 0.4% sodium chloride would be
131.4 mmol/L, a plasma level which may not have clini-
cal significance [27]. However, we are compelled to
speculate that this figure may not be exact because in
our illustrative case we dealt with hypothetical data that
may not necessary mirror the clinical setting. Hence,
our estimate has to be verified by means of water and
electrolyte balance measurement in vivo. Taken this
uncertainty into account, we arbitrarily decided that the
equality margin will be set at 5 mmol/L. This value will
capture our estimate, but, most importantly, in patients
whose p-Na
+ at T0 is 135 mmol/L, it would allow us to
identify those patients who are at risk for developing
hyponatremia of potential clinical significance [27].
Thus, a difference between treatment groups greater
than this margin will be considered as clinically relevant.
Consequently, a difference smaller than 5 mmol/L will
be considered as clinically less relevant. Sample size was
calculated assuming a standard deviation (SD) of 5
mmol/L, a significance level of 0.05, and a power of 80%
to detect a difference larger than the equality margin of
5 mmol/L. Hence, the number of patients per study arm
needed to fulfill the power goal of the study will be 17
patients.
Data analysis
All statistical analyses will be described in detail in the
statistical analysis plan. Data will be presented using
descriptive statistics, i.e., mean and SD for continuous
variables, and frequency and proportions for categorical
variables. The efficacy variable will be evaluated using
ANCOVA, intervention (parenteral maintenance fluid
therapy) as a fixed factor and baseline levels as a covari-
ate in the model. The corresponding 95% confidence
intervals for each group and the difference between
groups will also be presented. In addition, graphs will be
used in order to facilitate the interpretation of the
results regarding the equality margins to be used in the
present study.
Missing data will be replaced using a conservative
approach, which will be specified in the statistical analy-
sis plan. All tests will be two-sided and performed at the
significance level of 0.05.
Discussion
Post-operative symptomatic hyponatremia in patients
receiving intravenous maintenance fluid therapy may be
associated with severe cerebral dysfunction and high
mortality [44]. Our study intends therefore to address a
question that might have important clinical implications.
To put our study question into perspective, we summar-
ize the results of the most relevant pediatric studies
published so far on this topic.
A retrospective single-center study reported on the
incidence and clinical consequences of post-operative
hyponatremia in children [45]. Out of 145 pediatric
patients who met the criteria for further analysis, 16
children were identified as having had p-Na
+ <1 3 0
mmol/L during the 24 h following the surgical proce-
dure. In the post-operative period, the incidence of
hyponatremia was similar between patients receiving
hypotonic and isotonic fluid therapy. None of them
experienced neurological sequelae due to hyponatremia.
According to the data presented in this study, and by
excluding one patient because of pseudohyponatremia,
it seems that in 14 of the 15 patients the rate of infusion
of parenteral fluid therapy given over the 24 h following
the surgical procedure was almost equal (n = 8), equiva-
lent (n =4 ) ,o rh i g h e r( n = 2) than the average mainte-
nance fluid therapy that would otherwise be
recommended to healthy children under normal clinical
conditions [22]. This observation suggests that the
volume and not the composition of intravenous solu-
tions used for parenteral fluid therapy might have
accounted for the development of post-operative
hyponatremia.
One study, including medical and surgical patients fol-
lowed from 12 to 24 h after admission, found that the
prescription of 0.18% sodium chloride in 5% glucose (30
mmol/L Na
+) was associated with a significant fall in p-
Na
+ when compared with patients who received isotonic
saline (0.9% sodium chloride, 154 mmol/L Na
+) [6]. The
incidence of hyponatremia was not reported. Full main-
tenance parenteral fluid therapy was found to produce a
greater but not significant fall in p-Na
+ than the fluid
therapy administered at a restricted rate.
A separate investigation, also designed as a rando-
mized controlled study, conducted in critically ill medi-
cal and surgical patients, showed that at 24 h of starting
full maintenance parenteral fluid therapy the fall in p-
Na
+, often to mild hyponatremic levels, was higher in
patients receiving fluids with a sodium content < 100
mmol/L compared with patients receiving intravenous
solutions containing 140 mmol/L Na
+ [7].
Although the aforementioned investigations were
designed to provide the most reliable form of scientific
e v i d e n c e ,t h e yh a v es o m el i m itations that weaken the
power of the studies, e.g., study population heterogene-
ity, wide age-range groups, no water and electrolyte bal-
ance, no measurement of regulatory hormones, no
standardization of fluid therapy given intra-operatively,
and short follow-up. Still, these investigations are impor-
tant since they indicate that a hospital-acquired decrease
of p-Na
+ in patients receiving parenteral maintenance
fluid therapy may be avoidable.
A recent randomized trial comparing multiple post-
operative intravenous maintenance fluid treatment
groups determined the risk of hyponatremia in patients
aged between 6 months and 15 years admitted for either
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observed that 24 h after surgery, regardless of fluid rate,
i.e., either 100% or 50% maintenance fluid rate, there
was no difference in the incidence of hyponatremia
between patients who received 0.9% sodium chloride
and 0.45% sodium chloride. On multiple linear regres-
sion analysis, hypotonic fluid, but not rate, significantly
influenced the change in p-Na
+ from induction of
anesthesia to 24 h after surgery. It is important to
observe, that at this time-point after surgery, no patient
in either treatment arm group experienced a fall in p-
Na
+ below 130 mmol/L. This study did not report on
both the total intravenous volume prescribed after sur-
gery and urinary production, making therefore difficult
to analyze the role of water and electrolyte balance on
p-Na
+ values at 24 h after surgery.
Finally, in a previous prospective study investigating
the incidence of post-operative hyponatremia in pedia-
tric patients who uniformly received hypotonic parent-
eral fluid therapy at full maintenance rate [47], the
prevalence of hyponatremia, defined as p-Na
+ < 136
mmol/L, was 21% and 31% at 12 h and at 24 h following
surgery, respectively. Of note, no patient experienced a
decrease in p-Na
+ below 130 mmol/L, suggesting that
the inclusion of an hypotonic saline administration arm
in future clinical trials is a feasible option [48].
In the present paper we describe the objectives of our
study and the design to achieve them. Since no consen-
sus has been reached on post-operative fluid manage-
ment, the results of this investigation will contribute to
the evidence base for effective pediatric prescription of
parenteral maintenance fluid therapy in otherwise
healthy children and adolescents undergoing acute sur-
gery. Although our investigation will be conducted in a
homogeneous cohort of patients, we speculate that our
results would be of clinical importance, not only in
post- appendectomized children and adolescents but
also in other post-operative scenarios.
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